CORT
Price
$55.31
Change
+$0.87 (+1.60%)
Updated
Jan 17 closing price
Capitalization
5.8B
24 days until earnings call
FTRE
Price
$17.69
Change
-$0.12 (-0.67%)
Updated
Jan 17 closing price
Capitalization
1.59B
57 days until earnings call
Ad is loading...

CORT vs FTRE

Header iconCORT vs FTRE Comparison
Open Charts CORT vs FTREBanner chart's image
Corcept Therapeutics
Price$55.31
Change+$0.87 (+1.60%)
Volume$742.44K
Capitalization5.8B
Fortrea Holdings
Price$17.69
Change-$0.12 (-0.67%)
Volume$497.59K
Capitalization1.59B
CORT vs FTRE Comparison Chart
Loading...
CORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CORT vs. FTRE commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CORT is a Hold and FTRE is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (CORT: $55.31 vs. FTRE: $17.69)
Brand notoriety: CORT and FTRE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CORT: 92% vs. FTRE: 46%
Market capitalization -- CORT: $5.8B vs. FTRE: $1.59B
CORT [@Biotechnology] is valued at $5.8B. FTRE’s [@Biotechnology] market capitalization is $1.59B. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CORT’s FA Score shows that 2 FA rating(s) are green whileFTRE’s FA Score has 1 green FA rating(s).

  • CORT’s FA Score: 2 green, 3 red.
  • FTRE’s FA Score: 1 green, 4 red.
According to our system of comparison, CORT is a better buy in the long-term than FTRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CORT’s TA Score shows that 4 TA indicator(s) are bullish while FTRE’s TA Score has 1 bullish TA indicator(s).

  • CORT’s TA Score: 4 bullish, 3 bearish.
  • FTRE’s TA Score: 1 bullish, 6 bearish.
According to our system of comparison, CORT is a better buy in the short-term than FTRE.

Price Growth

CORT (@Biotechnology) experienced а +10.95% price change this week, while FTRE (@Biotechnology) price change was -2.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

CORT is expected to report earnings on Apr 30, 2025.

FTRE is expected to report earnings on Mar 17, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CORT($5.8B) has a higher market cap than FTRE($1.59B). CORT YTD gains are higher at: 9.764 vs. FTRE (-5.147). CORT has higher annual earnings (EBITDA): 145M vs. FTRE (7.1M). CORT has more cash in the bank: 380M vs. FTRE (105M). CORT has less debt than FTRE: CORT (6.79M) vs FTRE (1.2B). FTRE has higher revenues than CORT: FTRE (2.98B) vs CORT (629M).
CORTFTRECORT / FTRE
Capitalization5.8B1.59B365%
EBITDA145M7.1M2,042%
Gain YTD9.764-5.147-190%
P/E Ratio43.90N/A-
Revenue629M2.98B21%
Total Cash380M105M362%
Total Debt6.79M1.2B1%
FUNDAMENTALS RATINGS
CORT: Fundamental Ratings
CORT
OUTLOOK RATING
1..100
30
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
6
SMR RATING
1..100
38
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
17
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CORTFTRE
RSI
ODDS (%)
Bullish Trend 11 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 11 days ago
74%
Bearish Trend 11 days ago
85%
Momentum
ODDS (%)
Bullish Trend 11 days ago
80%
Bearish Trend 11 days ago
77%
MACD
ODDS (%)
N/A
Bearish Trend 11 days ago
62%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
80%
Bearish Trend 11 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
63%
Bearish Trend 11 days ago
72%
Advances
ODDS (%)
Bullish Trend 13 days ago
81%
Bullish Trend 13 days ago
71%
Declines
ODDS (%)
Bearish Trend 17 days ago
66%
Bearish Trend 11 days ago
78%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 11 days ago
50%
N/A
View a ticker or compare two or three
Ad is loading...
CORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FFND26.150.18
+0.69%
Future Fund Active ETF
DEEF28.350.13
+0.45%
Xtrackers FTSE Develop ex US Mulfact ETF
HYLB36.470.04
+0.11%
Xtrackers USD High Yield Corp Bd ETF
FLCO21.07N/A
-0.01%
Franklin Investment Grade Corporate ETF
CNRG63.38-0.61
-0.95%
SPDR® Kensho Clean Power ETF

CORT and

Correlation & Price change

A.I.dvisor indicates that over the last year, CORT has been loosely correlated with DNLI. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CORT jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CORT
1D Price
Change %
CORT100%
+1.60%
DNLI - CORT
45%
Loosely correlated
+1.20%
AGIO - CORT
43%
Loosely correlated
+1.89%
TENX - CORT
41%
Loosely correlated
-0.55%
ARCT - CORT
41%
Loosely correlated
-1.29%
OXBOF - CORT
40%
Loosely correlated
N/A
More

FTRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FTRE has been loosely correlated with RVNC. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if FTRE jumps, then RVNC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FTRE
1D Price
Change %
FTRE100%
-0.67%
RVNC - FTRE
34%
Loosely correlated
+12.54%
TECH - FTRE
33%
Loosely correlated
-0.35%
RIGL - FTRE
33%
Poorly correlated
+16.02%
CORT - FTRE
32%
Poorly correlated
+1.60%
MGTX - FTRE
31%
Poorly correlated
+5.56%
More